Search details
1.
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
Br J Cancer
; 130(6): 1036-1045, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38267634
2.
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial.
Lancet
; 401(10389): 1655-1668, 2023 05 20.
Article
in English
| MEDLINE | ID: mdl-37068504
3.
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
Gastric Cancer
; 27(1): 6-18, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37847333
4.
Digital Therapeutic (Mika) Targeting Distress in Patients With Cancer: Results From a Nationwide Waitlist Randomized Controlled Trial.
J Med Internet Res
; 26: e51949, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38663007
5.
GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level.
Gut
; 72(4): 612-623, 2023 04.
Article
in English
| MEDLINE | ID: mdl-35882562
6.
Effect of home-based online training and activity feedback on oxygen uptake in patients after surgical cancer therapy: a randomized controlled trial.
BMC Med
; 21(1): 293, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37553660
7.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-34807464
8.
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
BMC Cancer
; 22(1): 254, 2022 Mar 09.
Article
in English
| MEDLINE | ID: mdl-35264144
9.
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
BMC Cancer
; 22(1): 646, 2022 Jun 13.
Article
in English
| MEDLINE | ID: mdl-35692051
10.
Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic.
Future Oncol
; 18(25): 2857-2864, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35722882
11.
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer.
Future Oncol
; 2022 Jul 19.
Article
in English
| MEDLINE | ID: mdl-35852104
12.
Impact of molecular alterations on quality of life and prognostic understanding over time in patients with incurable lung cancer: a multicenter, longitudinal, prospective cohort study.
Support Care Cancer
; 30(4): 3131-3140, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34877613
13.
Cancer prevention in females with and without obesity: Does perceived and internalised weight bias determine cancer prevention behaviour?
BMC Womens Health
; 22(1): 511, 2022 12 09.
Article
in English
| MEDLINE | ID: mdl-36494719
14.
Predictive Value of Preoperative Endoscopic Ultrasound (EUS) After Neoadjuvant Chemotherapy in Locally Advanced Esophagogastric Cancer - Data From a Randomized German Phase II Trial.
Ultraschall Med
; 43(5): 514-521, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35226933
15.
Gastric cancer.
Lancet
; 396(10251): 635-648, 2020 08 29.
Article
in English
| MEDLINE | ID: mdl-32861308
16.
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.
Oncologist
; 26(6): e1058-e1065, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33687742
17.
Psychosocial aftercare of adolescent and young adult cancer survivors in Germany: Awareness, utilisation, satisfaction and associated factors.
Psychooncology
; 30(8): 1311-1321, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33739567
18.
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma.
Gastric Cancer
; 24(3): 721-730, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33755863
19.
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy.
Int J Mol Sci
; 22(15)2021 Jul 27.
Article
in English
| MEDLINE | ID: mdl-34360781
20.
Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis.
Support Care Cancer
; 28(1): 211-220, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31001695